<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01824641</url>
  </required_header>
  <id_info>
    <org_study_id>T113E4</org_study_id>
    <nct_id>NCT01824641</nct_id>
  </id_info>
  <brief_title>Physiologic Assessment of Thrombus Aspiration in Acute ST-segment Elevation Myocardial Infarction Patients</brief_title>
  <acronym>PATA-STEMI</acronym>
  <official_title>The Randomized Physiologic Assessment of Thrombus Aspiration in Patients With Acute ST-segment Elevation Myocardial Infarction Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Centre of Serbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Center of nuclear medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institute for histology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinical Centre of Serbia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Physiologic Assessment of Thrombus Aspiration in ST-segment Elevation Myocardial
      Infarction (PATA-STEMI) trial is a single center, prospective, randomized trial with a
      planned inclusion of 128 patients with the first ST-segment elevation myocardial infarction
      (STEMI). Patients are, before coronary angiography, randomly assigned to thrombus aspiration
      using 6 or 7 French Eliminate aspiration catheter (Terumo Medical Supply, Japan) or to
      conventional primary percutaneous coronary intervention (PCI). The primary endpoint is index
      of microcirculatory resistance (IMR), measured in infarct-related artery, in thrombus
      aspiration compared to conventional PCI group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background and Objective Routine thrombus aspiration is superior to conventional primary PCI
      in terms of improved myocardial perfusion in STEMI patients. However, myocardial perfusion
      after thrombus aspiration has not been evaluated by a quantitative, invasive method.
      Investigators intend to determine whether thrombus aspiration of the infarct-related artery
      increases myocardial perfusion, as measured by IMR, compared to conventional primary PCI.

      Study design PATA-STEMI is a single center, prospective, randomized trial with a planned
      inclusion of 128 patients with the first STEMI. Patients are randomly assigned, before
      coronary angiography, to thrombus aspiration using the 6 or 7 French Eliminate aspiration
      catheter (Terumo Medical Supply, Japan) or to conventional primary PCI. The IMR will be
      determined in infarct-related artery and non-infarct-related arteries without critical
      stenosis to measure microcirculatory resistance. The primary endpoint is defined as IMR in
      infarct-related artery in thrombus aspiration compared to conventional PCI group. Secondary
      end points are myocardial perfusion grade and resolution of ST-segment elevation, infarct
      size and left ventricle remodeling, as assessed by echocardiographic indices. Transthoracic
      echocardiography will be conducted within 24 hours and at 4 months after the primary PCI.

      Implications: If manual thrombus aspiration reduces microcirculatory resistance, indicating
      improved myocardial perfusion, as compared to conventional PCI, it might become the preferred
      strategy in patients with STEMI.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">November 2013</completion_date>
  <primary_completion_date type="Anticipated">May 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IMR (mmHg seconds) in thrombus aspiration compared to conventional PCI group</measure>
    <time_frame>At the end of the primary PCI , an expected average of 45 minutes after sheath insertion</time_frame>
    <description>IMR will be measured after final balloon inflation or stent implantation, an expected average of 45 minutes after sheath insertion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Resolution of ST-segment elevation</measure>
    <time_frame>at 60 minutes after guiding catheter removal</time_frame>
    <description>ST-segment resolution ≥70% at 60 minutes after guiding catheter removal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>myocardial blush grade (0-3)</measure>
    <time_frame>at final angiogram, an expected average of 55 minutes after sheath insertion</time_frame>
    <description>myocardial blush grade will be assessed after IMR measurements, following the final balloon inflation or stent implantation, an expected average of 55 minutes after sheath insertion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>infarct size assessed by peak enzyme release (Troponin, creatine kinase MB (CK-MB))</measure>
    <time_frame>in hospital course after primary PCI, an expected average of 5 days</time_frame>
    <description>infarct size will be determined based on peak enzyme release (Troponin, CK-MB) during in-hospital stay, an expected average of 5 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>indices of left ventricle remodeling on Echocardiography</measure>
    <time_frame>within 24 hours and at 4 months after primary PCI</time_frame>
    <description>left ventricle remodeling will be assessed on Echocardiography within 24 hours and at 4 months after primary PCI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>infarct size determined by SPECT</measure>
    <time_frame>within 7-14 days and at 4 months after primary PCI</time_frame>
    <description>infarct size will be determined by SPECT within 7-14 days and at 4 months after primary PCI</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Eliminate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eliminate aspiration catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional primary angioplasty</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients treated with conventional primary angioplasty</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Eliminate aspiration catheter</intervention_name>
    <description>Eliminate aspiration catheter</description>
    <arm_group_label>Eliminate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional primary angioplasty</intervention_name>
    <description>Primary angioplasty without thrombus aspiration</description>
    <arm_group_label>Conventional primary angioplasty</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All consecutive patients with STEMI

          -  chest pain onset ≤12h, or &gt;12 h with persistent ST-segment elevation

          -  hemodynamically stable patients

        Exclusion Criteria:

          -  patients without diagnosis of STEMI (pericarditis, for example)

          -  no written informed consent obtained

          -  prior Q or non-Q MI

          -  prior resuscitation

          -  prior thrombolysis

          -  prior surgical myocardial revascularisation

          -  life expectancy &lt;6 months

          -  periprocedural death
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dejan Orlic, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Center of Serbia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dejan Milasinovic, MD</last_name>
    <phone>+381113613653</phone>
    <email>dejan_milasinovic@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Goran Stankovic, MD, PhD</last_name>
    <phone>+381113615433</phone>
    <email>gorastan@sbb.rs</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinical center of Serbia</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Milorad Tesic, MD</last_name>
      <phone>+381113615433</phone>
      <email>misa.tesic@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Miodrag Ostojic, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Branko Beleslin, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Goran Stankovic, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sinisa Stojkovic, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vladan Vukcevic, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Milica Borovic, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dragana Sobic-Saranovic, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Milorad Tesic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dejan Milasinovic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Milan Dobric, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zlatko Mehmedbegovic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Milan Nedeljkovic, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Milorad Zivkovic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vladimir Dedovic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Center of Serbia</name>
      <address>
        <city>Belgrade</city>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dejan Orlic</last_name>
      <phone>+381113615433</phone>
    </contact>
    <investigator>
      <last_name>Dejan Orlic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Serbia</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2013</study_first_submitted>
  <study_first_submitted_qc>April 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 5, 2013</study_first_posted>
  <last_update_submitted>April 2, 2013</last_update_submitted>
  <last_update_submitted_qc>April 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinical Centre of Serbia</investigator_affiliation>
    <investigator_full_name>Dejan Orlic</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Acute myocardial infarction</keyword>
  <keyword>Manual thrombus aspiration</keyword>
  <keyword>Coronary physiology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

